当前位置:首页 - 行情中心 - 药明康德(603259) - 财务分析

药明康德

(603259)

  

流通市值:2732.73亿  总市值:3296.75亿
流通股本:24.73亿   总股本:29.84亿

药明康德(603259)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润46.71亿元,每股收益1.59元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益8477162.94万元,未分配利润5080016.56万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产10741448.13万元,负债2264285.19万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入12,435,776,568.2945,456,165,774.1832,856,716,508.8620,799,281,882.46
营业总成本7,433,446,073.3329,148,154,763.3521,256,267,707.6714,014,556,298.92
其他经营收益
营业利润5,614,936,555.1923,930,083,791.615,066,061,792.999,931,118,357.5
利润总额5,607,280,256.2123,906,151,246.4515,037,068,350.449,907,416,557.97
净利润4,670,513,981.3319,333,065,892.2612,206,193,461.268,660,348,120.54
每股收益
其他综合收益-273,737,529.63-449,776,946.3-95,953,157.33-37,885,690.49
综合收益总额4,396,776,451.718,883,288,945.9612,110,240,303.938,622,462,430.05
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计65,169,309,017.7861,677,055,890.4953,812,305,105.1242,588,730,423.99
非流动资产:
非流动资产合计42,245,172,323.4741,443,912,688.6240,793,830,310.9541,235,049,478.25
资产总计107,414,481,341.25103,120,968,579.1194,606,135,416.0783,823,779,902.24
流动负债:
流动负债合计19,041,485,532.719,235,268,205.2419,438,255,302.4720,518,915,049.34
非流动负债:
非流动负债合计3,601,366,399.653,637,986,772.353,695,382,808.92,895,783,098.1
负债合计22,642,851,932.3522,873,254,977.5923,133,638,111.3723,414,698,147.44
所有者权益(或股东权益):
归属于母公司股东权益合计84,221,755,533.7679,712,290,246.4470,948,120,408.1759,911,708,305.03
股东权益合计84,771,629,408.980,247,713,601.5271,472,497,304.760,409,081,754.8
负债和股东权益合计107,414,481,341.25103,120,968,579.1194,606,135,416.0783,823,779,902.24
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计13,560,976,178.6551,752,563,331.2836,111,478,614.8724,056,009,009.65
经营活动现金流出小计9,965,165,852.1234,549,401,709.2824,698,643,947.416,625,027,477.95
经营活动产生的现金流量净额3,595,810,326.5317,203,161,62211,412,834,667.477,430,981,531.7
投资活动产生的现金流量:
投资活动现金流入小计3,818,368,757.5224,467,836,005.7612,754,865,895.918,170,088,313.92
投资活动现金流出小计9,166,737,566.8126,412,945,914.6412,349,902,224.226,360,546,680.63
投资活动产生的现金流量净额-5,348,368,809.29-1,945,109,908.88404,963,671.691,809,541,633.29
筹资活动产生的现金流量:
筹资活动现金流入小计3,377,302,944.5121,137,042,474.8218,571,573,684.897,677,208,916.66
筹资活动现金流出小计3,452,282,426.8820,013,501,429.3618,148,916,382.2112,606,536,226.07
筹资活动产生的现金流量净额-74,979,482.371,123,541,045.46422,657,302.68-4,929,327,309.41
汇率变动对现金及现金等价物的影响-198,774,624.87-370,473,427.27-209,209,966.1-203,423,250.66
现金及现金等价物净增加额-2,026,312,59016,011,119,331.3112,031,245,675.744,107,772,604.92
期末现金及现金等价物余额27,429,517,958.9529,455,830,548.9525,475,956,893.3817,552,483,822.56
补充资料:
现金及现金等价物的净增加额-16,011,119,331.31-4,107,772,604.92
最新报告期:2026-04-29
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
国泰海通周航,余文心6.687.417.742026-04-29
中金公司俞波,张琎,吴婉桦5.716.41--2026-04-29
招银国际JillWu,BenchenHuang------2026-04-29
华泰证券代雯,李奕玮5.666.727.882026-04-28
华西证券崔文亮,徐顺利7.388.6810.122026-04-28
TOP↑